Faslodex rejected by NICE for NHS breast cancer use

February 2, 2018
Research and Development, Sales and Marketing AstraZeneca, Faslodex, NHS, NICE, UK, pharma

Bad news for breast cancer patients in the UK as the National Institute for Health and Care Excellence announces it …

Array BioPharma demands $192m after AstraZeneca refuses to pay royalties

February 2, 2018
Medical Communications, Sales and Marketing Array Biopharma, AstraZeneca, lawsuit, selemetinib

Array BioPharma has launched a lawsuit against AstraZeneca over allegations the latter has refused to pay royalties it owes for …

allergan

Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years

February 2, 2018
Medical Communications, Sales and Marketing Allergan, Avycaz, FDA, pharma, pneumonia

Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the …

stroke

Incidence of strokes in younger people rising

February 1, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, stroke

On the day that a new campaign for greater awareness of stroke symptoms has been released, new figures show that …

20170105_studio_profielfoto___marco_avila_05_web

Working Life: Marco Avila, Vice President of Medical Affairs, Teva Europe

February 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, Working Life

Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …

roche_glass_building

NICE approves Perjeta for routine use on NHS

February 1, 2018
Sales and Marketing Perjeta, Roche, biotech, drugs, pharma, pharmaceutical

NICE has given the nod to Roche’s Perjeta for routine first-line use, alongside Herceptin and chemotherapy, in patients with HER2-positive …

bellicum_pharma_give_credit

FDA halts Bellicum trial over brain disease in participants, shares crash 48%

February 1, 2018
Research and Development Bellicum Pharmaceuticals, FDA, encephalopathy, pharma, trial failure

Texas-based clinical-stage company Bellicum Pharmaceuticals has taken a massive stock hit after the FDA put a hold on its trials …

blood_testing

New blood test for Alzheimer’s offers hope

February 1, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

To say January was a bleak month for Alzheimer’s research would be something of an understatement: Pfizer ducked out of …

seattle_gen

Seattle in $614m move for Cascadian Therapeutics

January 31, 2018
Sales and Marketing Cascadian Theapeutics, HER2, Seattle Genetics, biotech, drugs, pharma, pharmaceutical

Things don’t always go quite according to plan in the biotech world – something both Seattle Genetics and Cascadian Therapeutics …

brenda_fitzgerald_official_photo

CDC Director resigns over tobacco stock scandal

January 31, 2018
Medical Communications Brenda Fitzgerald, CDC, US, pharma

Dr Brenda Fitzgerald, the Director of the Centers for Disease Control and Prevention, the United States’ leading national public health …

online

Ipsen promotes new CMO from within

January 31, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current …

breast_cancer_care

UK charity Breast Cancer Care receives £655,000 cash injection to expand end-of-treatment app

January 31, 2018
Research and Development Breast Cancer Care, National lottery, UK, breast cancer, charity, pharma

UK charity Breast Cancer Care (BCC) is set to expand the development of its end-of-treatment support app after receiving a …

NHS Digital lambasted for collusion with Home Office to deport migrants

January 31, 2018
Medical Communications, Research and Development NHS Digital, biotech, drugs, immigration, pharma, pharmaceutical

NHS Digital, the Department of Health and the Home Office have been strongly criticised for entering a memorandum of understanding …

Pfizer teams up with Indian Government to battle antimicrobial resistance

January 31, 2018
Medical Communications, Research and Development India, Pfizer, antimicrobial resistance, pharma

Pfizer has entered into a partnership with the Indian Council of Medical Research (ICMR) in an effort to fight antimicrobial …

2056752817_cb9ed652dd_z

Amazon makes first steps into healthcare, alongside big partners

January 31, 2018
Medical Communications, Research and Development Berkshire Hathaway, JPMorgan, amazon, biotech, drugs, pharma, pharmaceutical

Amazon’s move into the healthcare sector has been widely mooted over the last 12 months and it officially announced that …

amsterdam-1910176_960_720

Italy refuses to give up hope on EMA HQ

January 30, 2018
Medical Communications, Research and Development EMA, amsterdam, biotech, drugs, pharma, pharmaceutical

It is no secret that Milan was not best pleased that it was pipped to the post to host the …

dengvaxia

Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi

January 30, 2018
Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …

Apotex President resigns amidst Founder’s murder and allegations of accepting Teva secrets

January 30, 2018
Manufacturing and Production, Medical Communications Apotex, Jeremy Desai, Teva, pharma

Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug …

bob_hugin1

Celgene Executive Chairman Bob Hugin to retire

January 30, 2018
Manufacturing and Production, Medical Communications Bob Hugin, Celgene, pharma

Fresh from its acquisition of Juno Therapeutics, Celgene has announced that its Executive Chairman Bob Hurgin is to retire effective …

The Gateway to Local Adoption Series

Latest content